Clinical Trial Update: A Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR) [Phase 1]

View source ↗

Summary

This clinical trial update reports the termination of a Phase 1 study evaluating prednisolone in combination with SPI-62 for polymyalgia rheumatica.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polymyalgia Rheumatica

Drugs mentioned

• Prednisolone (Prednisolone)
• SPI-62

Snippet

Sponsor: Sparrow Pharmaceuticals | Conditions: Polymyalgia Rheumatica | Phase 1 | Status: TERMINATED